{
    "organizations": [],
    "uuid": "56f91e2074858451ac18cfd80002d674bfcf5df4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-aptose-biosciences-says-exercises/brief-aptose-biosciences-says-exercises-early-option-for-cg-806-license-from-crystalgenomics-idUSFWN1SE0DH",
    "ord_in_thread": 0,
    "title": "Aptose Biosciences Says Exercises Early Option For Cg-806 License From Crystalgenomics",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - Crystal Genomics Inc:\n* APTOSE BIOSCIENCES INC - EXERCISES EARLY OPTION FOR CG-806 LICENSE FROM CRYSTALGENOMICS\n* APTOSE BIOSCIENCES INC - CO OWNS GLOBAL RIGHTS TO DEVELOP AND COMMERCIALIZE CG-806 FOR ALL INDICATIONS OUTSIDE OF KOREA AND CHINA - LICENSED TERRITORY\n* APTOSE BIOSCIENCES- CRYSTALGENOMICS ELIGIBLE FOR REGULATORY AND SALES MILESTONE PAYMENTS, AS WELL AS ROYALTIES ON PRODUCT SALES IN LICENSED TERRITORY\n* APTOSE BIOSCIENCES INC - OPTION EXERCISE TRIGGERS A PAYMENT OF US $2.0 MILLION TO CRYSTALGENOMICS Source text for Eikon:\nOur ",
    "published": "2018-05-07T19:08:00.000+03:00",
    "crawled": "2018-05-08T16:51:34.038+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "crystal",
        "genomics",
        "inc",
        "aptose",
        "bioscience",
        "inc",
        "exercise",
        "early",
        "option",
        "license",
        "crystalgenomics",
        "aptose",
        "bioscience",
        "inc",
        "co",
        "owns",
        "global",
        "right",
        "develop",
        "commercialize",
        "indication",
        "outside",
        "korea",
        "china",
        "licensed",
        "territory",
        "aptose",
        "crystalgenomics",
        "eligible",
        "regulatory",
        "sale",
        "milestone",
        "payment",
        "well",
        "royalty",
        "product",
        "sale",
        "licensed",
        "territory",
        "aptose",
        "bioscience",
        "inc",
        "option",
        "exercise",
        "trigger",
        "payment",
        "u",
        "million",
        "crystalgenomics",
        "source",
        "text",
        "eikon"
    ]
}